ClinicalTrials.Veeva

Menu

Analgesic Benefits of Genicular Nerve Blocks of the Posterior Knee for Patients Undergoing ACL Reconstruction

Northwestern University logo

Northwestern University

Status and phase

Terminated
Phase 4

Conditions

Rupture of Anterior Cruciate Ligament

Treatments

Drug: Preservative free normal saline
Drug: Bupivacaine

Study type

Interventional

Funder types

Other

Identifiers

NCT02008617
STU00085894

Details and patient eligibility

About

Outpatients scheduled to have ACL surgery typically receive a femoral nerve block to provide analgesia for the front of the knee. Postoperatively, these patients will often report pain in the back of the knee. Local anesthetic infiltration of the posterior aspect of the knee results in blockade of the genicular nerves of the posterior knee. These nerves originate off of the tibial and common peroneal nerves and their blockade will result in improved posterior knee pain relief and may decrease narcotic consumption compared to patients who receive the same infiltration with normal saline.

Full description

Femoral nerve blocks are commonly used to provide postoperative analgesia for ACL surgery. The limitation of these blocks is the incomplete analgesia they provide of the knee joint subjecting the patient to posterior knee pain. As a result, some of these patients receive rescue sciatic blocks in the postoperative care unit to cover posterior knee pain. The sciatic block provides excellent analgesia for the posterior knee; however its blockade invariably affects other territories of the sciatic nerve such as the lower leg and foot. For ACL surgery, the loss of sensation and/or motor strength to this area is unnecessary and may make ambulation more difficult. The ability to ambulate with minimal assistance may be more important for a patient undergoing an outpatient surgery when compared to an inpatient surgery.

At the posterior knee, the sciatic nerve branches off into the tibial and common peroneal nerves which give rise to sensory fibers that innervate the posterior knee. We propose targeting these terminal fibers in the popliteal fossa by infiltrating local anesthetic between the distal femoral shaft and popliteal artery thereby providing posterior knee analgesia without affecting the lower leg.This application of this block has not been studied in patients having ACL surgery. A single interim analysis is scheduled after the data for 50 cases are available.

Enrollment

18 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. patients who are presenting for ACL reconstruction
  2. candidates for peripheral nerve blocks patients
  3. ASA 1-3

Exclusion criteria

  1. Patient refusal
  2. ASA Classification of 4 or higher
  3. Pre-existing neuropathy in the femoral or sciatic distribution
  4. Coagulopathy
  5. Infection at the site
  6. Non-English speaking or non-reading patients
  7. Chronic opioid use (>3months)
  8. Pregnancy
  9. Any other contra-indication to regional anesthesia
  10. Failed femoral nerve block
  11. Sciatic nerve block placed due to severe pain not managed by intravenous and oral agents.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

18 participants in 2 patient groups

Study Drug
Active Comparator group
Description:
Ultrasound guided posterior genicular nerve infiltration with 30mL of Bupivicaine 0.20% with epinephrine 1:300,000 (Study Drug)
Treatment:
Drug: Bupivacaine
Preservative free normal saline
Sham Comparator group
Description:
Ultrasound guided posterior genicular nerve infiltration posterior knee with 30mL of preservative free normal saline
Treatment:
Drug: Preservative free normal saline

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems